Adaptimmune, Noile-Immune announce collaboration to develop next-generation SPEAR T-cell products Aug. 28, 2019
2-75, a novel enzalutamide-HDAC inhibitor hybrid with efficacy in models of prostate cancer Aug. 28, 2019
Immunogenicity and efficacy animal studies of a new vaccine against Lassa virus confirm protection Aug. 28, 2019
Reversible, selective, potent BTK inhibitors identified by Tethering-fragment-based screening Aug. 28, 2019
RSS